Abstract
This study uses clinical registry data to assess achievement of low-density lipoprotein cholesterol reduction and lipid-lowering therapy prescribing patterns among adults aged 20 to 39 years with moderate to severe hypercholesterolemia.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Anticholesteremic Agents / therapeutic use*
-
Cholesterol, LDL / blood
-
Disease Management
-
Ezetimibe / therapeutic use*
-
Female
-
Guideline Adherence
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
-
Hypercholesterolemia / blood
-
Hypercholesterolemia / drug therapy*
-
Male
-
PCSK9 Inhibitors / therapeutic use*
-
Practice Guidelines as Topic
-
Practice Patterns, Physicians' / statistics & numerical data*
-
Registries
-
Severity of Illness Index
-
Sex Factors
-
Young Adult
Substances
-
Anticholesteremic Agents
-
Cholesterol, LDL
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
PCSK9 Inhibitors
-
Ezetimibe